Payer perspective regarding decisions for covering the costs of molecular assays in oncology and reimbursing oncologists for treatments provided to patients while navigating long turnaround times ...
Desai, MBBS, MD, assistant professor of thoracic medical oncology/head and neck medical oncology at Fox Chase Cancer Center ...
The state Department of Health is partnering with Diagnostic Laboratory Services and Clinical Laboratories of Ha-wai’i to encourage providers to do “reflex” hepatitis C testing, in hopes of screening ...
Among the top stories in infectious disease last week were research that found an intervention that included changing the electronic ordering system to encourage urinalysis reflex testing for ...
Molecular testing prior to first-line therapy in patients with stage IV nonsquamous non-small cell lung cancer (NSCLC): A survey of U.S. medical oncologists. This is an ASCO Meeting Abstract from the ...
Lymphocyte Infiltration in Breast Cancer: A Key Prognostic Factor That Should Not Be Ignored This study of mutation testing in patients with NSCLC 25 and other studies that are measuring other genetic ...
Kelly, MD, MBA, and participants discussed key considerations for biomarker testing in upper GI cancers. Biomarker status has ...
Please provide your email address to receive an email when new articles are posted on . CHARLOTTE, N.C. — Pupillary light reflex testing may hold potential in detecting a hyperarousal subtype of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results